Kilitch Company (Pharma) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 41 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.87 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit 250.52%
(FY 2023)
- Ebitda 49.93%
(FY 2023)
- Net Worth 0.05%
(FY 2023)
- Total Assets -0.61%
(FY 2023)
About Kilitch Company (Pharma)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹10.87 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukund Mehta, Bhavin Mehta, and Mira Mehta serve as directors at the Company.
- CIN/LLPIN
U24230MH1983PLC030632
- Company No.
030632
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Aug 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kilitch Company (Pharma)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukund Mehta  | Director | 06-Dec-1984 | Current |
| Bhavin Mehta | Director | 31-Mar-1998 | Current |
| Mira Mehta | Director | 26-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Kilitch Company (Pharma).
Kilitch Company (Pharma) Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 250.52% increase in profit. The company's net worth moved up by a moderate rise of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kilitch Company (Pharma)?
In 2023, Kilitch Company (Pharma) had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kilitch Drugs (India) Limited.Active 32 years 7 monthsMukund Mehta, Bhavin Mehta and 1 more are mutual person
- Monarchy Healthserve Private LimitedActive 17 years 10 months
Mukund Mehta, Bhavin Mehta and 1 more are mutual person
- Indo Ethiopian Chamber Of Commerce And IndustryActive 4 years 1 month
Mukund Mehta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 08 Mar 1999 | ₹10.69 Cr | Satisfied |
Bank Of Baroda Creation Date: 19 Feb 1994 | ₹1.15 M | Satisfied |
Bank Of Baroda Creation Date: 06 Apr 1993 | ₹0.60 M | Satisfied |
How Many Employees Work at Kilitch Company (Pharma)?
Kilitch Company (Pharma) has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kilitch Company (Pharma), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kilitch Company (Pharma)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
